Lexicon Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of LXRX for the last quarter is 1.65 M USD, and it's 45.75% higher compared to the previous quarter. The net income of Q2 24 is -53.43 M USD.